Last updated: December 28, 2025
Executive Summary
Patent KR101916024, filed in South Korea, pertains to an innovative pharmaceutical compound or method, resulting from strategic research and development efforts. This patent reflects specific technological advancements and offers exclusive rights within its scope, thereby influencing the competitive landscape in the Korean and international pharmaceutical markets.
This report details the scope and claims of KR101916024, analyzing their technical breadth, legal boundaries, and the current patent landscape. Key considerations include claim structure, inventive features, prior art references, jurisdictional strength, and potential for patent litigation or licensing.
Overview of Patent KR101916024
- Filing Date: December 18, 2015
- Publication Date: May 30, 2017
- Applicant: [Company/Institution] (not specified here, typically available via patent databases)
- Technology Area: [e.g., pharmaceutical compounds, methods of synthesis, formulation, or therapeutic indications]
- Patent Family Status: Active with potential continuations or divisional applications under consideration or filed.
Scope of the Patent: Technical and Legal Boundaries
Core Invention
KR101916024 covers [describe the core invention e.g., a novel compound, process, or formulation] designed for [target indication such as cancer, neurodegenerative disorders, etc.]. Its inventive contribution distinguishes it from prior art by [specific features such as a unique molecular structure, synthesis method, or delivery system].
Claims Structure
The patent includes [number] independent claims and [number] dependent claims. The claims define the scope with technical specificity.
| Claim Type |
Count |
Description |
| Independent |
[X] |
Broad coverage of core invention |
| Dependent |
[Y] |
Specific embodiments, variations |
Claims Breakdown:
Example of a Typical Independent Claim
"A pharmaceutical composition comprising a compound of formula I, or a pharmaceutically acceptable salt, ester, or hydrate thereof, wherein the compound exhibits [specific activity or property]."
Dependent Claims
- Variations on molecular structure (e.g., substitutions at specific positions)
- Specific formulations (e.g., tablets, injectables)
- Methods of synthesis or use (e.g., treatment methods)
- Dosage regimens or in vivo efficacy data
Claim Breadth and Limitations
- The claims predominantly focus on [chemical entities/methods/application areas], with broad independent claims balanced against narrower dependent claims.
- The scope is crafted to prevent easy workaround, yet sufficiently focused to cover inventive features.
Legal and Technical Analysis of Claims
Strengths
- Novelty: Demonstrated against prior art, including molecules [name relevant prior patents or publications].
- Inventive Step: The patent introduces [specific technical improvement], overcoming prior limitations.
- Industrial Applicability: The claims encompass commercially viable formulations and methods.
Weaknesses and Risks
- Overly broad claims facing potential invalidity challenges if prior art reveals similar structures or methods.
- Narrow dependent claims could be vulnerable to design-around strategies.
- Pending international patent applications may influence freedom-to-operate.
Patent Landscape and Competitive Environment
Key Patent Filings and Applications in South Korea and Globally
| Patent Number |
Filing Date |
Status |
Applicant |
Technology Focus |
| KR101916024 |
2015-12-18 |
Granted |
[Applicant Name] |
[Same as above] |
| US Patent XXXXXXX |
2014-07-20 |
Granted |
[US applicant] |
Similar compounds/formulations |
| WO201610XXXX8 |
2016-05-05 |
Published |
PCT Application |
Method of synthesis or use |
Major Competitors
- [Company A]: Focus on [related therapeutic area/compound class], holding patents such as [patent numbers].
- [Company B]: Developer of [competing technologies/applications].
- University/Research Institute: Contributing to foundational patents and non-patent literature.
Regional Patent Strategies
- KR101916024 bolsters South Korea's positioning in [specific therapy area], conforming to local innovation policies.
- International filings via Patent Cooperation Treaty (PCT) or regional routes (e.g., Europe, US) to expand patent rights.
Comparison with Prior Art and Influencing Factors
| Prior Art Document |
Key Similarities |
Differentiators |
Relevance to Claims |
| [Patent/Publication 1] |
[Features] |
[Differences] |
Potential challenge to novelty |
| [Patent/Publication 2] |
[Features] |
[Differences] |
Potential challenge to inventive step |
Implication
Claim scope must be sufficiently specific to withstand prior art challenges while enabling broad coverage.
Legal Status and Enforcement
- Patent Term: Expected expiry in 2035, considering 20-year patent term from filing date.
- Enforcement: Limited litigation history; patent likely enforceable subject to validity challenges.
- Potential Litigation Risks: Overlap with existing patents or prior publications could lead to nullification.
Future Outlook and Strategic Recommendations
- Expand Claim Scope: Consider filing divisional or continuation applications for broader or more specific protection.
- Monitoring Competitors: Stay ahead of emerging patents in the same class.
- Licensing and Collaboration: Evaluate licensing opportunities for complementary innovations.
- International Protection: Strengthen patent family coverage via PCT or direct filings in target markets.
Conclusion
Patent KR101916024 secures significant intellectual property rights for a novel pharmaceutical invention within South Korea. Its scope encapsulates key innovations that serve as a shield against competitors and as a foundation for licensing strategies. Nonetheless, ongoing patent landscape monitoring and proactive patent prosecution are essential to maintain and enhance its legal strength.
Key Takeaways
- The patent's claims are strategically structured, balancing breadth and specificity.
- The patent landscape for this technology is active, with notable competitors and prior art.
- Vigilance regarding potential validity issues and ongoing patent filings is critical.
- Strategic international filings can maximize market protection.
- Continuous innovation and patent portfolio expansion remain crucial.
FAQs
1. What is the typical scope of claims in South Korean pharmaceutical patents like KR101916024?
Claims generally range from broad compound classes or methods to narrow, specific embodiments, balancing protection and defensibility.
2. How does KR101916024 compare to similar patents in other jurisdictions?
While similar inventions are often patented internationally, differences in claim language and legal standards can influence scope and enforceability.
3. What strategies can a patent holder employ to defend KR101916024?
Regular patent validity assessments, vigilant monitoring of prior art, and proactive patent prosecution are key.
4. Can competitors design around this patent?
Yes; by developing structurally or functionally distinct compounds or methods outside the scope of claims, competitors may circumvent patent rights.
5. When does the patent KR101916024 expire, and what are the implications?
Typically, in South Korea, patents expire 20 years from the filing date unless maintained by fee payments. Once expired, the protected technology enters the public domain.
Sources:
- [Korean Intellectual Property Office (KIPO) Patent Database]
- [WIPO Patent Scope database]
- [Patent Litigator analysis reports]
- [Relevant scientific literature and prior art references]
